Rebecca Keenan, PA
Physician Assistant · Flanders, NJNPI 1164623740
Payments from drug & device makers
Across 622 payments — averaging $14.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$1K
- AbbVie$1K
- Pfizer$638
- GSK$570
- Boehringer Ingelheim$451
- plus $3K from 29 others
What the payments were for
- Food & beverage$8,936100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 135 | $2,037 |
| AstraZeneca | 66 | $1,085 |
| AbbVie | 85 | $1,012 |
| Pfizer | 75 | $638 |
| GSK | 40 | $570 |
| Boehringer Ingelheim | 29 | $451 |
| Lilly USA, LLC | 25 | $383 |
| Axsome Therapeutics, Inc. | 20 | $342 |
| Otsuka America Pharmaceutical, Inc. | 20 | $319 |
| Exact Sciences | 12 | $279 |
| Currax Pharmaceuticals LLC | 18 | $272 |
| Amgen | 15 | $234 |
| Merck | 14 | $219 |
| Bayer | 10 | $184 |
| Novartis | 12 | $154 |
| Bausch Health US, LLC | 7 | $110 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $96 |
| Esperion Therapeutics, Inc. | 5 | $81 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $62 |
| Medtronic | 2 | $47 |
| Amarin Pharma, Inc. | 3 | $44 |
| Biohaven Pharmaceuticals, Inc. | 3 | $43 |
| Lundbeck LLC | 2 | $37 |
| Seqirus USA Inc | 2 | $35 |
| Cranial Technologies, Inc | 2 | $29 |
| Althera Pharmaceuticals LLC | 2 | $29 |
| Johnson & Johnson | 1 | $20 |
| Abbott | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
How this compares
$8,936 in reported general payments places this provider in the 95th percentile of 2,726 physician assistant providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 23 | $31,931 |
| FarxigaDapagliflozin Propanediol | 20 | $23,909 |
| WegovySemaglutide | 13 | $19,587 |
| JanuviaSitagliptin Phosphate | 15 | $14,221 |
| EliquisApixaban | 16 | $8,473 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 43 | $1,063 |
| Rosuvastatin Calcium | 78 | $1,009 |
| Lisinopril | 67 | $860 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 28 | $839 |
| Levothyroxine Sodium | 66 | $799 |
| Atorvastatin Calcium | 93 | $784 |
| Amlodipine Besylate | 78 | $688 |
| Escitalopram Oxalate | 43 | $633 |
| SynthroidLevothyroxine Sodium | 13 | $620 |
| Pantoprazole Sodium | 33 | $532 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy | $2,037 | $51,51836 claims |
| AstraZenecaFarxiga | $1,085 | $23,90920 claims |
| MerckJanuvia | $219 | $14,22115 claims |
| PfizerEliquis | $638 | $8,47316 claims |
| AbbVieSynthroid | $1,012 | $62013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,726 physician assistant providers in New Jersey.
Other physician assistant in Flanders
- Alexa HetzelEast Windsor$750K
- Nicole Schmid DavisHamilton$148K
- Todd NewmanHoboken$73K
- Patrick McGinnShrewsbury$72K
- Tatiana Dell'aquilaNutley$43K
- Nicole ColucciRiverdale$36K
- Salvatore SciurbaMiddletown$25K
- Jacqueline CristiniEdison$22K
- Mark MazakLakewood$21K
- Andrea BarkerPrinceton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.